iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Cholangiocarcinoma (Bile Duct Cancer)

Cholangiocarcinoma (Bile Duct Cancer)

Diagnosis and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HepatologyOncologyGastroenterology

Clinical Guidelines

British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
National
ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up of biliary tract cancer
National
NICE Guidance: Ivosidenib for treating advanced cholangiocarcinoma
National
ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up: Biliary tract cancer
Local
NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers
Local

Recent iatroX Q&As

  • What are the key clinical features and risk factors to consider when suspecting cholangiocarcinoma in a patient?Updated: 8/22/2025
  • Which imaging modalities are recommended for the diagnosis of cholangiocarcinoma in primary care settings?Updated: 8/22/2025
  • What are the current guidelines for referring patients with suspected cholangiocarcinoma to specialist services?Updated: 8/22/2025
  • How should I manage a patient with confirmed cholangiocarcinoma in terms of palliative care options?Updated: 8/22/2025
  • What follow-up protocols should be in place for patients treated for cholangiocarcinoma to monitor for recurrence?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play